Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Down – Time to Sell?

Nihon Kohden Corporation (OTCMKTS:NHNKY)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $9.4825, but opened at $8.8675. Nihon Kohden shares last traded at $8.8925, with a volume of 1,436 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Nihon Kohden has an average rating of “Buy”.

Nihon Kohden Stock Performance

The company’s 50 day moving average price is $9.40 and its 200 day moving average price is $10.36. The company has a market cap of $1.57 billion, a price-to-earnings ratio of 15.53 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY) last posted its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. The business had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.48%. On average, equities research analysts forecast that Nihon Kohden Corporation will post 0.61 EPS for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.